Alivus Life Sciences Limited (NSE:ALIVUS)
1,081.15
+19.50 (1.84%)
At close: Mar 28, 2025, 3:30 PM IST
Alivus Life Sciences Revenue
Alivus Life Sciences had revenue of 6.42B INR in the quarter ending December 31, 2024, with 12.05% growth. This brings the company's revenue in the last twelve months to 22.74B, down -3.97% year-over-year. In the fiscal year ending March 31, 2024, Alivus Life Sciences had annual revenue of 22.83B with 5.64% growth.
Revenue (ttm)
22.74B
Revenue Growth
-3.97%
P/S Ratio
5.83
Revenue / Employee
11.29M
Employees
2,014
Market Cap
132.48B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |